{
    "2021-08-30": [
        [
            {
                "time": "",
                "original_text": "太平洋证券：各行业周观点精粹8月30日",
                "features": {
                    "keywords": [
                        "周观点",
                        "精粹"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "东吴证券维持益丰药房买入评级：内生外延双轮驱动，门店网络稳步扩张",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "买入评级",
                        "内生外延",
                        "门店扩张"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "财信证券首予益丰药房推荐评级：门店扩张速度加快，互联网业务收入增长迅速，目标价63.90-71元",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "推荐评级",
                        "门店扩张",
                        "互联网业务",
                        "目标价"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "互联网"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "达嘉维康供应商药品质量存隐忧 收购合作方未并表或为避嫌其说难自圆",
                "features": {
                    "keywords": [
                        "达嘉维康",
                        "供应商",
                        "药品质量",
                        "收购合作",
                        "隐忧"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "观察 │ 思派健康的“不可能三角”",
                "features": {
                    "keywords": [
                        "思派健康",
                        "不可能三角"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "75股今日获机构买入评级 7股上涨空间超50%",
                "features": {
                    "keywords": [
                        "机构买入评级",
                        "上涨空间"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "益丰药房(603939)2021年中报点评：业绩维持稳健高增 下半年有望逐季加速",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "中报点评",
                        "业绩稳健",
                        "高增",
                        "下半年加速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "养老金二季度现身116只股前十大流通股东榜",
                "features": {
                    "keywords": [
                        "养老金",
                        "二季度",
                        "前十大流通股东"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "327股获券商买入评级，中国平安目标涨幅达110.58%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "中国平安",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}